Diarrhea InfectiousNCT04602676
The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) Algorithm
A study testing Rehydration calculator application with DEP algorithm and Rehydration calculator application in people with Diarrhea Infectious and Algorithms, run by University of Utah at 2 sites in 2 countries.
Trial summary
This is a randomized crossover study, where clinicians will be randomized to periods where they will use a rehydration calculator application with or without the Diarrheal Etiology Prediction (DEP) algorithm. The crossover will include a washout period to reduce carryover effect. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Diarrhea Infectious, Algorithms, Decision Support Systems, Clinical
- What is being tested?
- Rehydration calculator application with DEP algorithm and Rehydration calculator application
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 18 Nov 2020to 5 Mar 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Physician providing acute care for children with diarrhea at study hospitals
- Available to answer survey questionnaire
Who cannot join
- Planning to leave the study site prior to completion of the research
- Inability to read
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
Bangladesh1 site
Enteric and Respiratory Infections Unit, Infectious Diseases Division, icddr,b
Dhaka
About this study
Official title: The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) Algorithm Among Physicians Treating Children With Diarrhea
This is a randomized crossover study, where clinicians will be randomized to periods where they will use a rehydration calculator application with or without the Diarrheal Etiology Prediction (DEP) algorithm. The crossover will include a washout period to reduce carryover effect. The study will be conducted over a 9-week period. The Investigators will use a random number generator to randomize clinicians to DEP (use of the etiology calculator) or control arm (use of a previously-tested rehydration calculator) within site for the first 4 weeks. After the first 4 weeks, there will be 1-week washout period without decision support, after which each clinician will cross-over to the other arm for the next 4 weeks.
The Investigators will enroll diarrhea-treating clinicians who treat children presenting with acute diarrhea at sites in Bangladesh and Mali. Utah investigators will only analyze de-identified data provided by our collaborators in Bangladesh and Mali.
Read the detailed description
Diarrhoeal diseases are a leading cause of morbidity and mortality in children worldwide, with an estimated one billion cases and 500,000 deaths annually. While the majority of deaths due to diarrhoea occur in lower-income countries, infectious diarrhoea remains a significant problem in high-income countries. Aside from the immediate morbidity, potential long-term sequelae of diarrhoea in children in low-resource settings include malnutrition, growth faltering, and deficits in cognitive development.
While the cornerstone of diarrhoeal disease management in children is rehydration, a number of other management decisions, including the use of antibiotics and laboratory testing, may impact the course of disease. Overuse of antibiotics may cause side-effects and lead to increased antimicrobial resistance in the community. Underuse of antimicrobials for some bacterial and protozoal pathogens may lead to prolonged duration of illness and facilitate transmission. This can result in increased days of school or parental work missed, and among malnourished children in resource-poor settings, potential for growth faltering or death. Overuse of laboratory testing may have financial impact on both the patient and the healthcare system, and underuse may delay appropriate therapy or prevent recognition of outbreaks. Thus, accurate and cost-effective determination of diarrhoea etiology is important for proper case management in children and for public health.
Clinical prediction rules (CPRs) help clinicians interpret clinical information and can improve decision making. A recent systematic review showed that out of 137 studies of conditions for which clinical prediction rules have been developed for children only 2 were for diarrhoea, both of which are for the assessment of dehydration. Similarly, the majority of available guidelines for pediatric diarrhoea are focused on the route, timing, and choice of fluids for rehydration. A few studies in the past 30 years studied the use of clinical predictors to estimate the probability of a bacterial cause of diarrhoea. However, these studies were limited by low rates of pathogen identification, small sample sizes, use of a single study site, and suboptimal prediction performance.
Given the lack of guidelines and effective clinical predictors, decisions for use of antibiotics and laboratory testing are mostly empiric in nature, based on a number of "rules of thumb" for which evidence is scant. Unfortunately, physician judgment does very poorly to predict both need for antibiotics and correct type of testing. A recent study of children presenting to Kenyan hospitals with diarrhoea showed that reliance on dysentery as a proxy for Shigella infection led to the failure to diagnose Shigellosis in nearly 90% of cases. Better tools for decision making and evidence-based guidelines regarding use of antibiotics and laboratory testing in children with diarrhoea are clearly needed.
The majority of decisions for use of antibiotics in diarrhoeal illnesses are made empirically. In lower- and middle-income countries (LMICs), due to cost constraints, etiological diagnosis is rarely made, and a large number (up to 70%) of patients with acute diarrhoea are prescribed antibiotics. However, in contrast to high resource settings, bacterial pathogens may be very common in low resource settings. In the multicenter Global Enteric Multicenter Study (GEMS) study, the investigators found that detection of Shigella ranged from 16-78% of children with dysentery and 2-43% of children with watery diarrhoea. In both high and low resource settings, inappropriate use of antimicrobials leads to unnecessary toxicity for the individual, increased costs and an increase in antibiotic resistance in the community. Thus, methods for guiding appropriate use of antibiotics for pediatric diarrhoea in both high- and low-resource settings are urgently needed.
Clinical prediction rules (CPRs) are decision-making rubrics that help clinicians estimate the likelihood of a patient outcome. A number of prominent prediction scores have been widely adopted for clinical use. Examples include the CHADS2 score for stroke risk in patients with atrial fibrillation, the TIMI score for mortality in patients with NSTEMI, and the CURB-65 Score for mortality in community-acquired pneumonia. Clinical prediction rules integrated into clinical decision-making have the ability to direct clinicians towards more evidence-based behaviors, resulting in improved care and reduction of costs. CPRs can also reduce antimicrobial usage, as shown by the use of scores for strep pharyngitis, and linking CPRs with testing guidance may further reduce antimicrobial usage. Thus, clinical prediction rules have the potential to help healthcare workers worldwide address clinical uncertainty and provide improved care for children with diarrhoea.
The investigators have recently use data from GEMS to derive a viral etiology prediction rule with an internal cross-validated area under the curve (AUC) of approximately 0.85. The investigators used a post-test odds formulation method, which takes into account odds from multiple models or tests. First, using data from GEMS, the investigators trained a logistic regression model with viral etiology as dependent variable using the five most predictive clinical variables as independent variables. The investigators then trained models with the same viral etiology response using both local climate and recent clinical trends as independent variables. For each model, odds of viral etiology versus other known aetiologies are generated by estimating the conditional distribution of training predictions using kernel density estimates. The odds generated for each model are multiplied along with a pre-test odds to determine an overall odds of a viral etiology. The investigators have now transferred the calculation of this prediction rule into a smart-phone application, called the Diarrheal Etiology Prediction (DEP) algorithm. The investigators have used TAC data from the VIDA (Vaccine Impact on Diarrhea in Africa) study to externally validate the DEP algorithm's ability to predict viral etiology of diarrhea. In this application, our objective is to determine the acceptability and use of the DEP among clinicians caring for children with diarrhea.
- Conditions
- Diarrhea Infectious, Algorithms, Decision Support Systems, Clinical, Clinical Decision-Making
- Being tested
- Rehydration calculator application with DEP algorithm, Rehydration calculator application
- Keywords
- Diarrhea, Treatment Algorithm
- Medical subject headings
- Dysentery, Diarrhea
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rehydration calculator application with DEP algorithmDiagnostic test
4 week period where clinicians will use a rehydration calculator application with the DEP algorithm followed by a 1 week washout period.
Rehydration calculator applicationDiagnostic test
4 week period where clinicians will use a rehydration calculator application without the DEP algorithm followed by a 1 week washout period.
| Study group | Role | What they receive |
|---|---|---|
| Diarrheal Assessment with DEP, then diarrheal assessment | Experimental | Participants will go through a 4 week period where clinicians will use a rehydration calculator application with the DEP algorithm. After a washout period of 1 week, they will go through a 4 week period where clinicians will use a rehydration calculator application. Receives: Diagnostic Test: Rehydration calculator application with DEP algorithm; Diagnostic Test: Rehydration calculator application |
| Diarrheal Assessment, then Diarrheal assessment with DEP | Experimental | Participants will go through a 4 week period where clinicians will use a rehydration calculator. After a washout period of 1 week, they will go through a 4 week period where clinicians will use a rehydration calculator application with the DEP algorithm. Receives: Diagnostic Test: Rehydration calculator application with DEP algorithm; Diagnostic Test: Rehydration calculator application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of antibiotic prescriptions given to patients with diarrhea
Measured: 9 weeks
Secondary outcomes (2)
Proportion of patients with resolution of diarrheal symptoms at 10-days after enrollment
Measured: 10 days
Clinician satisfaction towards use of the DEP as assessed by pre- and post-study questionnaires.
Measured: 9 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2020
- Study start18 Nov 2020
- Primary completion5 Mar 2021
- Study completion5 Mar 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Diarrhea InfectiousStudies of the same condition, open and under way.
- More trials run by University of UtahThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Utah
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Daniel Leung, University of Utah
- Investigators
- Daniel Leung, MD, Principal investigator, University of Utah
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04602676
- Sponsor's protocol ID
- IRB_00135830
- Status last verified
- Apr 2021
- First submitted
- 6 Oct 2020
- Last updated
- 20 Apr 2021
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Nelson EJ, Khan AI, Keita AM, Brintz BJ, Keita Y, Sanogo D, Islam MT, Khan ZH, Rashid MM, Nasrin D, Watt MH, Ahmed SM, Haaland B, Pavia AT, Levine AC, Chao DL, Kotloff KL, Qadri F, Sow SO, Leung DT. Improving Antibiotic Stewardship for Diarrheal Disease With Probability-Based Electronic Clinical Decision Support: A Randomized Crossover Trial. JAMA Pediatr. 2022 Oct 1;176(10):973-979. doi: 10.1001/jamapediatrics.2022.2535.
PubMed 36036920
Study at a glance
From the registry record, last updated by the sponsor on 20 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) Algorithm Among Physicians Treating Children With Diarrhea
- ClinicalTrials.gov ID
- NCT04602676
- Acronym / sponsor ID
- IRB_00135830
- Conditions
- Diarrhea Infectious, Algorithms, Decision Support Systems, Clinical, Clinical Decision-Making
- Keywords
- Diarrhea, Treatment Algorithm
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- University of UtahUniversity, hospital or other
- Study start
- 18 Nov 2020 (actual)
- Primary completion
- 5 Mar 2021 (actual)
- Study completion
- 5 Mar 2021 (actual)
- First posted
- 26 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a randomized crossover study, where clinicians will be randomized to periods where they will use a rehydration calculator application with or without the Diarrheal Etiology Prediction (DEP) algorithm. The crossover will include a washout period to reduce carryover effect. The study will be conducted over a 9-week period. The Investigators will use a random number generator to randomize clinicians to DEP (use of the etiology calculator) or control arm (use of a previously-tested rehydration calculator) within site for the first 4 weeks. After the first 4 weeks, there will be 1-week washout period without decision support, after which each clinician will cross-over to the other arm for the next 4 weeks.
The Investigators will enroll diarrhea-treating clinicians who treat children presenting with acute diarrhea at sites in Bangladesh and Mali. Utah investigators will only analyze de-identified data provided by our collaborators in Bangladesh and Mali.
Detailed description
Diarrhoeal diseases are a leading cause of morbidity and mortality in children worldwide, with an estimated one billion cases and 500,000 deaths annually. While the majority of deaths due to diarrhoea occur in lower-income countries, infectious diarrhoea remains a significant problem in high-income countries. Aside from the immediate morbidity, potential long-term sequelae of diarrhoea in children in low-resource settings include malnutrition, growth faltering, and deficits in cognitive development.
While the cornerstone of diarrhoeal disease management in children is rehydration, a number of other management decisions, including the use of antibiotics and laboratory testing, may impact the course of disease. Overuse of antibiotics may cause side-effects and lead to increased antimicrobial resistance in the community. Underuse of antimicrobials for some bacterial and protozoal pathogens may lead to prolonged duration of illness and facilitate transmission. This can result in increased days of school or parental work missed, and among malnourished children in resource-poor settings, potential for growth faltering or death. Overuse of laboratory testing may have financial impact on both the patient and the healthcare system, and underuse may delay appropriate therapy or prevent recognition of outbreaks. Thus, accurate and cost-effective determination of diarrhoea etiology is important for proper case management in children and for public health.
Clinical prediction rules (CPRs) help clinicians interpret clinical information and can improve decision making. A recent systematic review showed that out of 137 studies of conditions for which clinical prediction rules have been developed for children only 2 were for diarrhoea, both of which are for the assessment of dehydration. Similarly, the majority of available guidelines for pediatric diarrhoea are focused on the route, timing, and choice of fluids for rehydration. A few studies in the past 30 years studied the use of clinical predictors to estimate the probability of a bacterial cause of diarrhoea. However, these studies were limited by low rates of pathogen identification, small sample sizes, use of a single study site, and suboptimal prediction performance.
Given the lack of guidelines and effective clinical predictors, decisions for use of antibiotics and laboratory testing are mostly empiric in nature, based on a number of "rules of thumb" for which evidence is scant. Unfortunately, physician judgment does very poorly to predict both need for antibiotics and correct type of testing. A recent study of children presenting to Kenyan hospitals with diarrhoea showed that reliance on dysentery as a proxy for Shigella infection led to the failure to diagnose Shigellosis in nearly 90% of cases. Better tools for decision making and evidence-based guidelines regarding use of antibiotics and laboratory testing in children with diarrhoea are clearly needed.
The majority of decisions for use of antibiotics in diarrhoeal illnesses are made empirically. In lower- and middle-income countries (LMICs), due to cost constraints, etiological diagnosis is rarely made, and a large number (up to 70%) of patients with acute diarrhoea are prescribed antibiotics. However, in contrast to high resource settings, bacterial pathogens may be very common in low resource settings. In the multicenter Global Enteric Multicenter Study (GEMS) study, the investigators found that detection of Shigella ranged from 16-78% of children with dysentery and 2-43% of children with watery diarrhoea. In both high and low resource settings, inappropriate use of antimicrobials leads to unnecessary toxicity for the individual, increased costs and an increase in antibiotic resistance in the community. Thus, methods for guiding appropriate use of antibiotics for pediatric diarrhoea in both high- and low-resource settings are urgently needed.
Clinical prediction rules (CPRs) are decision-making rubrics that help clinicians estimate the likelihood of a patient outcome. A number of prominent prediction scores have been widely adopted for clinical use. Examples include the CHADS2 score for stroke risk in patients with atrial fibrillation, the TIMI score for mortality in patients with NSTEMI, and the CURB-65 Score for mortality in community-acquired pneumonia. Clinical prediction rules integrated into clinical decision-making have the ability to direct clinicians towards more evidence-based behaviors, resulting in improved care and reduction of costs. CPRs can also reduce antimicrobial usage, as shown by the use of scores for strep pharyngitis, and linking CPRs with testing guidance may further reduce antimicrobial usage. Thus, clinical prediction rules have the potential to help healthcare workers worldwide address clinical uncertainty and provide improved care for children with diarrhoea.
The investigators have recently use data from GEMS to derive a viral etiology prediction rule with an internal cross-validated area under the curve (AUC) of approximately 0.85. The investigators used a post-test odds formulation method, which takes into account odds from multiple models or tests. First, using data from GEMS, the investigators trained a logistic regression model with viral etiology as dependent variable using the five most predictive clinical variables as independent variables. The investigators then trained models with the same viral etiology response using both local climate and recent clinical trends as independent variables. For each model, odds of viral etiology versus other known aetiologies are generated by estimating the conditional distribution of training predictions using kernel density estimates. The odds generated for each model are multiplied along with a pre-test odds to determine an overall odds of a viral etiology. The investigators have now transferred the calculation of this prediction rule into a smart-phone application, called the Diarrheal Etiology Prediction (DEP) algorithm. The investigators have used TAC data from the VIDA (Vaccine Impact on Diarrhea in Africa) study to externally validate the DEP algorithm's ability to predict viral etiology of diarrhea. In this application, our objective is to determine the acceptability and use of the DEP among clinicians caring for children with diarrhea.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Diarrheal Assessment with DEP, then diarrheal assessment | Experimental | Diagnostic Test: Rehydration calculator application with DEP algorithm, Diagnostic Test: Rehydration calculator applicationParticipants will go through a 4 week period where clinicians will use a rehydration calculator application with the DEP algorithm. After a washout period of 1 week, they will go through a 4 week period where clinicians will use a rehydration calculator application. |
| Diarrheal Assessment, then Diarrheal assessment with DEP | Experimental | Diagnostic Test: Rehydration calculator application with DEP algorithm, Diagnostic Test: Rehydration calculator applicationParticipants will go through a 4 week period where clinicians will use a rehydration calculator. After a washout period of 1 week, they will go through a 4 week period where clinicians will use a rehydration calculator application with the DEP algorithm. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Physician providing acute care for children with diarrhea at study hospitals
- Available to answer survey questionnaire
Key exclusion criteria (2 listed)
- Planning to leave the study site prior to completion of the research
- Inability to read
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rehydration calculator application with DEP algorithm4 week period where clinicians will use a rehydration calculator application with the DEP algorithm followed by a 1 week washout period. | Diagnostic test | Diarrheal Assessment with DEP, then diarrheal assessment, Diarrheal Assessment, then Diarrheal assessment with DEP |
| Rehydration calculator application4 week period where clinicians will use a rehydration calculator application without the DEP algorithm followed by a 1 week washout period. | Diagnostic test | Diarrheal Assessment with DEP, then diarrheal assessment, Diarrheal Assessment, then Diarrheal assessment with DEP |
Primary outcome
Proportion of antibiotic prescriptions given to patients with diarrhea
Time frame: 9 weeks
2 secondary outcomes
Proportion of patients with resolution of diarrheal symptoms at 10-days after enrollment
Time frame: 10 days
Clinician satisfaction towards use of the DEP as assessed by pre- and post-study questionnaires.
Time frame: 9 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Apr 2021.
- Derived from this study: PubMed 36036920Nelson EJ, Khan AI, Keita AM, Brintz BJ, Keita Y, Sanogo D, Islam MT, Khan ZH, Rashid MM, Nasrin D, Watt MH, Ahmed SM, Haaland B, Pavia AT, Levine AC, Chao DL, Kotloff KL, Qadri F, Sow SO, Leung DT. Improving Antibiotic Stewardship for Diarrheal Disease With Probability-Based Electronic Clinical Decision Support: A Randomized Crossover Trial. JAMA Pediatr. 2022 Oct 1;176(10):973-979. doi: 10.1001/jamapediatrics.2022.2535.
- Individual participant dataSharing planned: No
Related trials for Diarrhea Infectious
RecruitingPhase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
RecruitingObservational study
Natural History of Clostridioides Difficile Infection
Clostridium Difficile Infection, Health Care Associated Infection
Recruiting
Evaluating the LGG of on Acute Infectious Diarrhea in Children
Acute Infectious Diarrhoea in Children
Not yet recruiting
Effectiveness of Saccharomyces Boulardii in Prevention of Antibiotic Associated Diarrhea
Antibiotic Associated Diarrhea, Upper Respiratory Tract Infection
RecruitingPhase 4
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Diarrhea, Gastroenteritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Daniel Leung, MD principal investigator
University of Utah
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Rehydration calculator application with DEP algorithm and Rehydration calculator application in people with Diarrhea Infectious and Algorithms, run by University of Utah at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Bangladesh, Mali. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of antibiotic prescriptions given to patients with diarrhea (time frame: 9 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04602676, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2021.